Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 472.45
+8.35 (1.80%)
Nov 12, 2026, 3:30 PM IST
Cohance Lifesciences Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 20,575 | 22,686 | 26,085 | 10,514 | 13,403 | 13,202 |
Revenue Growth | 69.95% | -13.03% | 148.11% | -21.56% | 1.52% | 30.75% |
Gross Profit Gross Profit Growth | 12,831 | 14,643 | 16,655 | 6,797 | 7,521 | 7,461 |
Operating Income Operating Income Growth | 292.4 | 2,413 | 6,606 | 3,544 | 5,262 | 5,416 |
Net Income Net Income Growth | 473.7 | 1,792 | 4,873 | 3,003 | 4,113 | 4,538 |
Earnings Per Share EPS Growth | 1.23 | 4.68 | 12.68 | 11.80 | 16.16 | 17.83 |
EPS Growth | -82.13% | -63.10% | 7.53% | -26.99% | -9.37% | 25.27% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
USA USA Growth | 6,725 | 6,351 | 1,477 | 833.9 |
Europe Europe Growth | 7,219 | 10,944 | 7,362 | 11,618 |
India India Growth | 3,171 | 3,491 | 964.4 | 259.34 |
Rest of The World Rest of The World Growth | 5,291 | 4,802 | 536.5 | 600.13 |
Total Total Growth | 22,407 | 25,588 | 10,341 | 13,311 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,929 | 3,201 | 2,979 | 8,211 | 4,837 | 5,258 |
Total Debt Total Debt Growth | 4,484 | 4,005 | 4,859 | 650.1 | 703.41 | 971.27 |
Net Cash (Debt) Net Cash Growth | -1,555 | -803.7 | -1,881 | 7,561 | 4,134 | 4,287 |
Net Cash Growth | - | - | - | 82.90% | -3.56% | 858.10% |
Net Cash Per Share Net Cash Per Share Growth | -4.04 | -2.10 | -4.90 | 29.70 | 16.24 | 16.84 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,952 | 3,683 | 6,734 | 3,848 | 4,572 | 3,300 |
Capital Expenditures CapEx Growth | -2,382 | -2,199 | -3,168 | -518.8 | -2,859 | -751.87 |
Free Cash Flow Free Cash Flow Growth | 570.6 | 1,484 | 3,566 | 3,329 | 1,713 | 2,548 |
Free Cash Flow Growth | -58.23% | -58.37% | 7.11% | 94.35% | -32.78% | -6.21% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 62.36% | 64.55% | 63.85% | 64.65% | 56.11% | 56.51% |
Operating Margin | 1.42% | 10.64% | 25.33% | 33.71% | 39.26% | 41.02% |
Pretax Margin | 0.33% | 9.13% | 24.64% | 38.59% | 41.76% | 50.57% |
Profit Margin | 2.30% | 7.90% | 18.68% | 28.56% | 30.69% | 34.37% |
FCF Margin | 2.77% | 6.54% | 13.67% | 31.66% | 12.78% | 19.30% |
Fiscal Year | FY 2023 | FY 2022 |
|---|---|---|
| Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 3.000 | 2.000 |
Dividend Per Share Growth | 50.00% | 0% |
Dividend Yield | 0.64% | 0.32% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 384.31 | 64.35 | 60.12 | 57.40 | 29.24 | 34.69 |
Forward PE | 68.00 | 39.98 | 63.44 | 44.40 | 26.23 | 30.48 |
P/FCF Ratio | 316.79 | 77.69 | 82.18 | 51.78 | 70.21 | 61.79 |
PS Ratio | 8.79 | 5.08 | 11.23 | 16.40 | 8.97 | 11.93 |